This topic contains a solution. Click here to go to the answer

Author Question: The United States helped negotiate GATT but ironically has refused to sign the agreement. Indicate ... (Read 65 times)

magmichele12

  • Hero Member
  • *****
  • Posts: 559
The United States helped negotiate GATT but ironically has refused to sign the agreement.
  Indicate whether the statement is true or false

Question 2

Was the fact that the plaintiff had better performance evaluations than the younger worker promoted to the job evidence of discriminatory intent because of age?



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

raili21

  • Sr. Member
  • ****
  • Posts: 324
Answer to Question 1

F

Answer to Question 2

No. The evidence that the plaintiff had better performance evaluations could only be used to convince the jury that the company made a bad employment decision, not that their mistake was motivated by an animus towards the plaintiff because of her age.




magmichele12

  • Member
  • Posts: 559
Reply 2 on: Jun 24, 2018
YES! Correct, THANKS for helping me on my review


epscape

  • Member
  • Posts: 335
Reply 3 on: Yesterday
Gracias!

 

Did you know?

Approximately one in three babies in the United States is now delivered by cesarean section. The number of cesarean sections in the United States has risen 46% since 1996.

Did you know?

It is important to read food labels and choose foods with low cholesterol and saturated trans fat. You should limit saturated fat to no higher than 6% of daily calories.

Did you know?

Human neurons are so small that they require a microscope in order to be seen. However, some neurons can be up to 3 feet long, such as those that extend from the spinal cord to the toes.

Did you know?

Aspirin is the most widely used drug in the world. It has even been recognized as such by the Guinness Book of World Records.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library